Adventure Brand Announces New Safety Protocols and Services to address new CDC Guidelines
In light of the of the Executive Order on "Promoting COVID-19 Safety in Domestic and International Travel," Aggressor Adventures® announces today its Return Travel Testing Services available to travelers returning to the United States and other countries that require negative COVID-19 test results. This new offering includes a visit from a medical lab tech who will arrive at Aggressor’s destinations at the end of the adventure to administer a rapid antigen test.
"The comfort and safety of guests remains our top priority. Our new Return Travel Testing Services offer peace of mind to travelers and allow for our guests to enjoy a stress-free Adventure of a Lifetime," says Wayne Brown, CEO of Aggressor Adventures. "Additionally, we created a Know Before You Go Supplement that provides each guest with helpful information specific to the destination they are traveling to with us. These documents can be printed from our website and provide answers to several frequently asked questions, and we are always available to answer any additional questions from our guests."
Operational Aggressor Adventure destinations currently offering Return Travel Testing Services include Belize Aggressor III & Belize Aggressor IV, Okeanos Aggressor I & Okeanos Aggressor II, Galapagos Aggressor III, Red Sea Aggressor II, Red Sea Aggressor III, Maldives Aggressor II, Socorro Aggressor, Roatan Aggressor, Turks & Caicos Aggressor II and the Aggressor Nile Queen River Cruise. Before traveling, Aggressor Adventures recommends each guest review the travel restrictions applied by each country, the specific airline regulations, and the entry requirements of the destination.
Industry Leading Protocols for Passengers Required to Quarantine
Each Aggressor Adventure destination has established a local professional medical support team to advise them should a staff member or guest become ill and develop a fever or other symptoms. Temperatures of staff are taken twice daily. Once out on the adventure, Aggressor instructs guests to self-monitor and report to the Captain/Safari Guide if they develop a fever or other symptoms. Should symptoms be detected, the Aggressor team will immediately contact the local medical support team for a consultation. If possible, transportation is arranged for the patient to visit the medical facility for evaluation. While awaiting transport, the guest will be asked to self-isolate in their Stateroom/Chalet.
For passengers who test positive for COVID-19, Aggressor has a plan in place with one or more locally approved quarantine hotels and will assist the guest with travel to the hotel, along with assistance to re-book their return flight. The guest will absorb the costs of evacuation, land accommodations and medical services. Aggressor highly recommends that guests review their travel and medical insurance for COVID-19 coverage should this occur.
"Travel restrictions and guidelines are changing at a rapid pace. That’s why we’ve taken the proactive approach to integrate protocols for our guests to help them travel safely," says Brown. "We are grateful for all customers who decide to travel with us and will continue to work diligently to ensure they have an Adventure of a Lifetime."
For more information on Aggressor Adventures COVID-19 policies and procedures, visit www.Aggressor.com.
About Aggressor Adventures
Since 1984, Aggressor Adventures® has offered travelers liveaboard scuba and snorkeling charters, luxury river cruises and exotic wildlife safaris. Worldwide locations the company explores include Bahamas, Belize, Cayman Islands, Cocos Island, Costa Rica, Cuba, Djibouti, Dominican Republic, Egypt, Galapagos, Hawaii, Indonesia, Maldives, Mexico, Oman, Palau, Red Sea, Roatan, Sri Lanka, Sudan, Thailand, and Turks and Caicos. For more information, visit www.aggressor.com or call (800) 348-2628 or (706) 993-2531.
View source version on businesswire.com: https://www.businesswire.com/news/home/20210127005088/en/
For media inquiries or photos, contact:
(800) 348-2628 or (706) 993-2531